Just a moment, the page is loading...
Welcome to the Janssen Oncology & Haematology IIS Website
Janssen Oncology
Selected Products:
Clear AllClose



Clinical Application Details


Drug:

Daratumumab

Status:

Currently Accepting Clinical IIS Applications




New research proposals may be submitted and if received by 31 August, 2019 will be reviewed in Sept/October 2019.
Click "Submit Application" below to begin the process.